Bausch Health Companies BHC Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.31B+13.4% | $1.33B+10.3% | $1.34B+78.7% | $1.74B+180% | $1.16B+53.2% | ||
| $5.98B+4.3% | $6.16B+6.6% | $6.25B+16.8% | $6.51B+25.0% | $5.73B+6.2% | ||
| $2.1B+11.3% | $2.07B+16.5% | $2.03B+13.2% | $1.99B+14.7% | $1.88B+9.9% | ||
| $9.81B-12.1% | $11.27B+1.7% | $11.29B+1.0% | $11.3B+1.5% | $11.15B-0.1% | ||
| $2.61B-25.5% | $2.85B-48.7% | $3.03B-23.2% | $3.25B-22.6% | $3.5B-21.9% | ||
| $24.5B-7.3% | $26.37B-0.6% | $26.82B+1.1% | $27.27B+2.9% | $26.42B-1.8% | ||
| $593M-4.4% | $600M+1.9% | $616M-7.6% | $627M+8.3% | $620M-3.4% | ||
| $889M+215% | $225M-91.6% | $579M+27.8% | $879M+94.5% | $282M-47.6% | ||
| $4.53B+6.4% | $4.18B-38.1% | $4.79B+6.4% | $4.98B+13.9% | $4.26B-3.4% | ||
| $19.88B-6.4% | $20.59B+8.7% | $20.46B-2.8% | $20.86B-1.6% | $21.23B-1.4% | ||
| $25.58B-4.1% | $25.99B-3.2% | $26.47B-1.2% | $27.12B+1.5% | $26.66B-1.6% | ||
| $10.54B+0.3% | $10.52B+0.2% | $10.52B+0.2% | $10.51B+0.3% | $10.51B+0.3% | ||
| -$11.09B-12.2% | -$9.67B+1.6% | -$9.56B+3.7% | -$9.73B+1.0% | -$9.88B-0.4% | ||
| -$2.06B-74.0% | -$554M+56.7% | -$565M+51.9% | -$764M+35.0% | -$1.18B-6.1% | ||
| $24.5B-7.3% | $26.37B-0.6% | $26.82B+1.1% | $27.27B+2.9% | $26.42B-1.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Bausch Health Companies cover its short-term obligations?
- Its current ratio is 1.32 — current assets exceed current liabilities.
- Where does Bausch Health Companies's balance sheet data come from?
- Every line is extracted from Bausch Health Companies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.